Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group

Department of Medicine, Duke University Medical Center, Durham, North Carolina.

To determine the clinical profile and efficacy of accelerated recombinant tissue-type plasminogen activator (rt-PA) dose regimens, five different strategies of thrombolytic therapy in a total of 232 patients were systematically evaluated in the setting of acute myocardial infarction. The fifth strategy involved a combination of accelerated rt-PA and intravenous urokinase (regimen E). A weight-adjusted dose of 1.25 mg/kg body weight of tissue plasminogen activator over 90 min (regimen C) yielded the highest coronary patency rate (83%) at acute angiography. The associated in-hospital reocclusion rate for this regimen was low (4%). An exaggerated (60-min) dosage regimen yielded an inferior coronary patency rate (63%). Combination therapy (regimen E) was associated with a 72% patency rate and 3% reocclusion rate. Marginal improvement in global ejection fraction and regional wall function was demonstrated with all strategies by predischarge catheterization. Bleeding complications were most common at the periaccess site and were not different from those in previous experiences reported with conventional 3-h dosing regimens. Measurements of baseline, 30-min and 3-h levels of tissue plasminogen activator, fibrinogen and fibrin(ogen) degradation products were obtained. At 3 h, fibrinogen levels of less than 1 g/liter were demonstrated with combination therapy (regimen E) as well as with regimen C. Major clinical outcomes including death, reocclusion and reinfarction also showed a tendency to be less common with regimen C. Therefore, although accelerated dose regimens of rt-PA do not reliably yield acute coronary patency rates greater than 85%, an acute coronary patency rate of approximately 85% can be approached.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				G. Ndrepepa, J. Mehilli, S. Schulz, R. Iijima, D. Keta, R. A. Byrne, J. Pache, M. Seyfarth, A. Schomig, and A. Kastrati Prognostic Significance of Epicardial Blood Flow Before and After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes J. Am. Coll. Cardiol., August 12, 2008; 52(7): 512 - 517. [Abstract] [Full Text] [PDF]

				L. M. Brass, J. H. Lichtman, Y. Wang, J. H. Gurwitz, M. J. Radford, and H. M. Krumholz Intracranial Hemorrhage Associated With Thrombolytic Therapy for Elderly Patients With Acute Myocardial Infarction : Results From the Cooperative Cardiovascular Project Stroke, August 1, 2000; 31(8): 1802 - 1811. [Abstract] [Full Text] [PDF]

				A. Shah, G. S. Wagner, C. B. Granger, C. M. O'Connor, C. L. Green, K. M. Trollinger, R. M. Califf, and M. W. Krucoff Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis: Reexamining the "gold standard" for myocardial reperfusion assessment J. Am. Coll. Cardiol., March 1, 2000; 35(3): 666 - 672. [Abstract] [Full Text] [PDF]

				R. H. Christenson and H. M. E. Azzazy Biochemical markers of the acute coronary syndromes Clin. Chem., August 1, 1998; 44(8): 1855 - 1864. [Abstract] [Full Text] [PDF]

				H. D. White and F. J. J. Van de Werf Thrombolysis for Acute Myocardial Infarction Circulation, April 28, 1998; 97(16): 1632 - 1646. [Abstract] [Full Text] [PDF]

				R. H. Christenson, E. M. Ohman, E. J. Topol, S. Peck, L. K. Newby, S.-H. Duh, D. J. Kereiakes, S. J. Worley, G. L. Alosozana, T. C. Wall, et al. Assessment of Coronary Reperfusion After Thrombolysis With a Model Combining Myoglobin, Creatine Kinase–MB, and Clinical Variables Circulation, September 16, 1997; 96(6): 1776 - 1782. [Abstract] [Full Text]

				S. Anand and S. L. Diamond Computer Simulation of Systemic Circulation and Clot Lysis Dynamics During Thrombolytic Therapy That Accounts for Inner Clot Transport and Reaction Circulation, August 15, 1996; 94(4): 763 - 774. [Abstract] [Full Text]

				R.J. Simes, E. J. Topol, D. R. Holmes Jr, H. D. White, W. R. Rutsch, A. Vahanian, M. L. Simoons, D. Morris, A. Betriu, R. M. Califf, et al. Link Between the Angiographic Substudy and Mortality Outcomes in a Large Randomized Trial of Myocardial Reperfusion : Importance of Early and Complete Infarct Artery Reperfusion Circulation, April 1, 1995; 91(7): 1923 - 1928. [Abstract] [Full Text]

				C. L. Grines, E. J. Topol, W. W. O'Neill, B. S. George, D. Kereiakes, H. R. Phillips, J. D. Leimberger, L. H. Woodlief, and R. M. Califf Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Myocardial Infarction Circulation, January 15, 1995; 91(2): 298 - 303. [Abstract] [Full Text]

				C. L. Grines, K. F. Browne, J. Marco, D. Rothbaum, G. W. Stone, J. O'Keefe, P. Overlie, B. Donohue, N. Chelliah, G. C. Timmis, et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction N. Engl. J. Med., March 11, 1993; 328(10): 673 - 679. [Abstract] [Full Text]